02361 SINOHEALTH HLDG
- 4.520
- -0.010-0.22%
SINOHEALTH HLDG News
SINOHEALTH HLDG: 2024 INTERIM REPORT
Zhongkang Holdings (02361): Wanchuan resigns as joint company secretary.
Zhongkang Holdings (02361) announced that Wanchuan has resigned from the position of co-company secretary of the company, effective September 1, 2024...
Hong Kong stock market anomaly | Zhongkang Holdings (02361) rose more than 10% at the close. Both revenue and profit achieved double-digit growth in the first half of the year, promoting the digital transformation of the health industry by the company.
China Health Holdings (02361) rose after the results, with the closing stock price up more than 10%, as of the time of publication, up 10.65%, at HKD 5.09.
Health industry digital transformation pioneer, Zhongkang Holdings (02361) continuously releases long-term value.
How will Zhongkang Holdings leverage research and development innovation to achieve value leap in the face of the current pressure and challenges in the pharmaceutical industry, and how will it seek new market opportunities?
Understanding the mid-term performance of China National HealthCare Holdings (02361) in 2024 with one picture
Understanding the mid-term performance of China National HealthCare Holdings (02361) in 2024 with one picture
Zhongkang Holdings (02361.HK) achieved revenue of 0.16 billion yuan in the first half of the year, an increase of approximately 10.1% year-on-year.
On August 28, GeLongHui announced that as of June 30, 2024, in the six months of the reporting period, benefited from the continuous development of the industrial cooperation network and the continuous innovation of products and business, the customer base and prices of smart retail cloud and saas products have risen, thereby driving further improvement in the group's revenue scale and operational efficiency, with revenue of approximately RMB 0.16 billion, a year-on-year growth of approximately 10.1%; leading big data processing technology and a continuously solidified data platform construction have greatly improved technological efficiency, thus driving the continuous optimization of the group's cost efficiency and nurturing
In the performance report, Zhongkang Holdings (02361.HK) recorded a net profit of 41.675 million yuan, a decrease of 12.9%.
Zhongkang Holdings (02361.HK) announced its interim performance as of the end of June this year, with revenue of 160 million yuan Renminbi (RMB) and a 10.1% year-on-year increase. Net profit was 41.675 million yuan, a 12.9% year-on-year decrease; earnings per share were 0.1 yuan. No dividend distributed.
SINOHEALTH HLDG: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024
Chicony (02361.HK) will hold a board of directors meeting on August 28 to approve its mid-term performance.
On August 16th, Guolonghui reported that the board of directors of Zhongkang Holdings (02361.HK) will hold a meeting on August 28th, 2024, to consider and approve the semi-annual performance of the company and its subsidiaries ending on June 30th, 2024, and to consider the distribution of interim dividends (if any).
SINOHEALTH HLDG To Go Ex-Dividend On June 24th, 2024 With 0.0725 HKD Dividend Per Share
June 19th (Beijing Time) - $SINOHEALTH HLDG(02361.HK)$ is trading ex-dividend on June 24th, 2024.Shareholders of record on June 25th, 2024 will receive 0.0725 HKD dividend per share on September 25th,
Sinohealth Holdings Profit Nearly Doubles in 2023
Zhongkang Holdings (02361): Release the value of data elements to achieve new high performance and create new momentum for the digital transformation of the healthcare industry
Following financial data, energy, medical and other industry data is expected to become a new important component of data transactions.
SINOHEALTH HLDG: 2023 ANNUAL REPORT
Zhongkang Holdings (02361) will pay a final dividend of HK$0.0725 per share on September 25
Zhongkang Holdings (02361) announced that it will be distributed on September 25, 2024 until December 3, 2023...
Zhongkang Holdings (02361) announced annual results. Profit attributable to shareholders of 102 million yuan increased by 82.99% year-on-year
Zhongkang Holdings (02361) announced its annual results for the year ended December 31, 2023. The group will take...
SINOHEALTH HLDG: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Zhongkang Holdings (02361.HK) plans to hold a board meeting on March 28 to approve the annual results
Gelonghui, March 18, 丨 Zhongkang Holdings (02361.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider recommending payment of a final dividend (if any).
Shanghai Tianyi Assets Management Co., Ltd sold 7.05 million common shares of Zhongkang Holdings (02361.HK) worth approximately HK$30.02 million
On March 15, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on March 15, 2023, Shanghai Tianyi Assets Management Co., Ltd sold $7.505 million common shares of $Zhongkang Holdings (02361.HK) at an average price of HK$4.0 per share, worth approximately HK$30.02 million. After the sale, the latest shareholding of Shanghai Tianyi Assets Management Co., Ltd. was 22.8543 million shares
Shanghai Xuanyu Enterprise Management Co., Ltd. (Shanghai Xuanyu Enterprise Management Co., Ltd.) sold 7.05 million common shares of Zhongkang Holdings (02361.HK), worth approximately HK$30.02 million
It was reported on March 15 that, according to documents disclosed by the Hong Kong Stock Exchange on March 15, 2023, Shanghai Xuanyu Enterprise Management Co., Ltd. (Shanghai Xuanyu Enterprise Management Co., Ltd.) sold $7.505 million common shares of $Zhongkang Holdings (02361.HK) at an average price of HK$4.0 per share, worth approximately HK$30.02 million. After the sale, Shanghai Xuanyu Enterprise Management Co.
Sinohealth Holdings Forecasts 85% Rise in 2023 Profit
Analysis
Price Target
No Data
No Data